IRIS
RADAELLI, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.679
AS - Asia 2.260
NA - Nord America 2.142
SA - Sud America 529
Continente sconosciuto - Info sul continente non disponibili 102
AF - Africa 37
Totale 7.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.033
RU - Federazione Russa 1.457
SG - Singapore 874
CN - Cina 728
BR - Brasile 454
SE - Svezia 308
RO - Romania 266
HK - Hong Kong 230
VN - Vietnam 207
IT - Italia 164
FR - Francia 121
DE - Germania 109
GB - Regno Unito 81
CA - Canada 47
IN - India 42
FI - Finlandia 37
BD - Bangladesh 33
NL - Olanda 33
AR - Argentina 29
MX - Messico 28
JP - Giappone 23
PL - Polonia 22
ZA - Sudafrica 21
IR - Iran 20
ID - Indonesia 19
TR - Turchia 18
IE - Irlanda 17
EC - Ecuador 16
ES - Italia 14
IQ - Iraq 12
AT - Austria 10
CO - Colombia 10
UA - Ucraina 8
JM - Giamaica 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
MY - Malesia 6
PK - Pakistan 6
CH - Svizzera 5
CL - Cile 5
JO - Giordania 5
LT - Lituania 5
MD - Moldavia 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
NI - Nicaragua 4
PH - Filippine 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AL - Albania 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
PE - Perù 3
SV - El Salvador 3
UY - Uruguay 3
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 7.649
Salva come PNG Salva come JPEG
Città #
Singapore 365
Dallas 305
Moscow 278
San Jose 266
Hong Kong 227
Ashburn 193
Council Bluffs 115
Shanghai 105
Hefei 103
Beijing 98
Lauterbourg 88
Ho Chi Minh City 85
Princeton 73
Lawrence 72
New York 69
Munich 64
Los Angeles 56
São Paulo 44
Milan 43
Phoenix 41
Hanoi 37
Boardman 34
Orem 32
Santa Clara 32
Denver 19
Helsinki 19
Warsaw 19
Manchester 18
Rome 17
Chicago 16
Dublin 16
Montreal 16
Tokyo 16
Chennai 14
Johannesburg 14
Rio de Janeiro 14
Seattle 14
Turku 14
Amsterdam 13
Atlanta 13
Da Nang 13
Guangzhou 13
Mexico City 13
Ankara 12
Brooklyn 12
London 12
Houston 11
Mumbai 11
Poplar 11
Brasília 10
Haiphong 10
Nuremberg 10
Stockholm 10
The Dalles 10
Frankfurt am Main 9
Toronto 9
Vienna 9
Baghdad 8
Barnet 8
Dronten 8
Tehran 8
Tianjin 8
Ribeirão Preto 7
Tashkent 7
Washington 7
Florence 6
Jacksonville 6
Pune 6
Amman 5
Belo Horizonte 5
Bergamo 5
Campinas 5
Charlotte 5
City of London 5
Duque de Caxias 5
Kingston 5
Las Vegas 5
Medellín 5
Miami 5
Osasco 5
Philadelphia 5
Piscataway 5
Porto Alegre 5
Querétaro 5
Quito 5
Shenzhen 5
Zurich 5
Aracaju 4
Boston 4
Buenos Aires 4
Cesano Boscone 4
Changsha 4
Cotia 4
Curitiba 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Hangzhou 4
Izmir 4
Jackson 4
Totale 3.488
Salva come PNG Salva come JPEG
Nome #
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 358
Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations 185
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 183
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 134
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 128
Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography 126
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis 115
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 114
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene 112
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 108
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 107
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 107
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients 102
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 102
Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica 101
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 99
the multiple sclerosis knowledge Questionnaire: a self administered instrument of recently diagnosed patients 97
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 97
Application of deep-learning to NMOSD and unclassified seronegative patients 91
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO) 91
Dysregulation of MS risk genes and pathways at distinct stages of disease 89
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis 88
Brain and cord imaging features in neuromyelitis optica spectrum disorders 87
Breastfeeding is not related to postpartum relapses in multiple sclerosis 83
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 82
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 82
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 80
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 78
Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. 78
Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis 77
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 77
Clinical and MRI predictors of response to interferon‐beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients 75
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD 73
Critical role for prokineticin 2 in CNS autoimmunity 73
Experience of an information aid for newly diagnosed multiple sclerosis patients: A qualitative study on the SIMS-Trial 73
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach 71
Artificial Intelligence on Conventional Magnetic Resonance Images for the Diagnosis of Neuromyelitis Optica Spectrum Disorders 71
Are Recurrent Myelitis a Prodromic Phase of Inflammatory Diseases or a Distinct Inflammatory Condition? 70
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 70
THIOTEPA-CYCLOPHOSPHAMIDE HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AGGRESSIVE FORMS OF MULTIPLE SCLEROSIS: RESULTS IN 9 PATIENTS 70
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: A post-marketing observational study 70
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 70
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 70
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: An Italian multicenter study 69
Neuromyelitis optica spectrum disorders: Long-term safety and efficacy of rituximab in Caucasian patients 69
Brain and Spinal Cord Imaging Features in Neuromyelitis Optica Spectrum Disorders 69
Forceps minor damage and co-occurence of depression and fatigue in multiple sclerosis 68
Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder 68
Mitoxantrone: benefits and risks in multiple sclerosis patients 67
Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation in aggressive forms of multiple sclerosis: results in 9 patients 65
Natalizumab treatment after autologous haematopoietic stem cell transplantation in patients with aggressive multiple sclerosis 65
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 65
Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study 64
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis. 63
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report 63
Evolving concepts in the treatment of relapsing multiple sclerosis 63
Sars-CoV2 infection in pregnant women with multiple sclerosis 62
Efficacy and safety of nabiximols (Sativex (R)) on multiple sclerosis spasticity in a real-life Italian monocentric study 62
Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment 62
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 62
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results 62
Optical coherence tomography and visual-evoked potentials: which is more sensitive in multiple sclerosis? 61
MGAT5 and disease severity in progressive multiple sclerosis 61
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks. 61
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. 61
Practice of yoga may cause damage of bothsciaticnerves: a case report 60
Evoked potentials scores: a useful tool in monitoring and predicting the course of multiple sclerosis? 60
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 60
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis 60
Disclosing the diagnosis of multiple sclerosis: The Profile Project 60
Evoked Potential Abnormalities Predict Disability Progression at 5 Years in Patients with CIS 59
Oral corticosteroids for multiple sclerosis relapse 58
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood 58
Signs and symptoms of COVID-19 in patients with multiple sclerosis 57
Neuromyelitis optica: Concepts in evolution 57
Multiple sclerosis progression is not associated with birth timing in Italy 56
Stem Cell-Based Therapies, Remyelination, and Repair Promotion in the Treatment of Multiple Sclerosis 55
White Matter Myelin Alterations are Diffuse in Neuromyelitis Optica Spectrum Disorders and Prevail on Axonal Damage 55
Recurrence of disease activity after repeated Natalizumab withdrawals. 54
Regional gray matter atrophy is largely unrelated to white matter tissue loss in relapsing remitting multiple sclerosis. 54
Evoked potential abnormalities predict disability progression at 5 years in patients with CIS 54
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. 54
White matter myelin alterations are diffuse in Neuromyelitis Optica spectrum disorders and prevail on axonal damage 54
Global and regional hippocampal volumes are preserved in neuromyelitis optica spectrum disorders and do not contribute to cognitive impairment 53
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial. 53
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. 53
Spinal cord atrophy in neuromyelitis optica is spatially associated to spinal cord lesions and clinical disability 52
Differential diagnosis of optic neuritis in neuromyelites optica and multiple sclerosis: are VEPs useful? 51
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. 51
Hippocampal regional vulnerability to damage differs between MS and neuromyelitis optica 50
NMO spectrum disorder and optic neuritis: are VEPs useful? 49
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression 49
Golbal and Regional Hippocampal Volumes Are Preserved In Neuromyelitis Optica and Do not Seem to Be Related to Cognitive Impairment 48
Revealing structural and clinical heterogeneity in the spectrum of neuromyelitis optica with unsupervised machine learning 46
Hippocampal Regional Vulnerability to Damage Differs Between MS and Neuromyelitis Optica 46
Hippocampal Regional Vulnerability to Damage Differs Between MS and Neuromyelitis Optica 45
White matter myelin alterations are diffuse in Neuromyelitis Optica Spectrum Disorders and prevail on axonal damage 45
Global and regional hippocampal volumes are preserved in neuromyelitis optica spectrum disorders and do not seem to be related to cognitive impairment 44
Revealing structural and clinical heterogeneity in the spectrum of neuromyelitis optica with unsupervised machine learning 44
Spinal cord atrophy in neuromyelitis optica spectrum disorders is associated to spinal cord lesions and clinical disability 44
Totale 7.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 30 1 2 1 3 2 3 0 2
2022/2023504 182 129 55 2 5 60 19 15 19 6 9 3
2023/2024229 7 26 22 26 27 42 4 20 0 7 10 38
2024/20251.593 130 14 20 59 69 85 434 102 262 131 121 166
2025/20264.737 339 376 378 679 350 187 357 314 1.291 263 112 91
2026/2027588 75 271 226 16 0 0 0 0 0 0 0 0
Totale 7.749